{"id":17944,"date":"2025-10-06T14:33:00","date_gmt":"2025-10-06T14:33:00","guid":{"rendered":"http:\/\/tezgyan.com\/index.php\/2025\/10\/06\/foreign-investment-inflows-us-pharma-firm-eli-lilly-to-invest-1-billion-in-telangana-details-here-business-news\/"},"modified":"2025-10-06T14:33:00","modified_gmt":"2025-10-06T14:33:00","slug":"foreign-investment-inflows-us-pharma-firm-eli-lilly-to-invest-1-billion-in-telangana-details-here-business-news","status":"publish","type":"post","link":"https:\/\/tezgyan.com\/index.php\/2025\/10\/06\/foreign-investment-inflows-us-pharma-firm-eli-lilly-to-invest-1-billion-in-telangana-details-here-business-news\/","title":{"rendered":"Foreign Investment Inflows: US Pharma Firm Eli Lilly to Invest $1 Billion In Telangana; Details Here | Business News"},"content":{"rendered":"


\n<\/p>\n

\n

Last Updated:<\/span>

Eli Lilly will invest $1 billion in Telangana to expand its manufacturing base and strengthen its global medicine supply chain.<\/h2>\n
<\/p>\n
\n
\n
\n
\"font\"<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n
\"It<\/p>\n

It will increase the availability of Lilly’s key drugs, including those for obesity, diabetes, Alzheimer’s, cancer and autoimmune conditions.<\/p>\n<\/figure>\n

US-based pharmaceutical giant Eli Lilly will invest $1 billion (over Rs 8,800 crore) in Telangana to expand its manufacturing base and strengthen its global medicine supply chain, the state government announced on Monday.<\/p>\n

The investment was confirmed after a delegation from Eli Lilly met Chief Minister A Revanth Reddy and Industries Minister D Sridhar Babu at the Integrated Command Control Centre in Hyderabad.<\/p>\n

According to an official release, \u201cTelangana secured a massive investment of $1 billion by US pharma major Eli Lilly, which will expand its manufacturing and global medicine supply capacity in Hyderabad.”<\/p>\n

The expansion plan includes a new manufacturing and quality presence, which is expected to create significant employment opportunities for the state\u2019s youth. The move will increase the availability of Lilly\u2019s key drugs, including those for obesity, diabetes, Alzheimer\u2019s, cancer and autoimmune conditions.<\/p>\n

\u201cWe are making significant investments to increase manufacturing and medicine supply capacity around the world,” Patrik Jonsson, president of Lilly International, said, adding, India is a hub for capability building within its global network.<\/p>\n

Chief Minister Revanth Reddy said the move reinforces Hyderabad\u2019s position as a global hub for healthcare innovation, while Minister Sridhar Babu added that the investment underlines Telangana\u2019s rapid industrial growth and growing influence in advanced healthcare manufacturing.<\/p>\n

Eli Lilly already operates a commercial site in Gurugram and specialised centres in Bengaluru and Hyderabad supporting its global operations. The new facilities will further enhance its local technical capabilities and broaden its manufacturing footprint in India.<\/p>\n

Last month, Lilly announced a $5 billion investment in a new facility in Virginia, part of a $27 billion expansion plan to build four new US plants over the next five years.<\/p>\n

Meanwhile, the India launch of Mounjaro, alongside Danish drugmaker Novo Nordisk\u2019s Wegovy, has increased patient awareness of obesity treatments in a country projected to have the world\u2019s second-largest obese population by 2050.<\/p>\n

Sales of both drugs doubled within months of their launch.<\/p>\n

Lilly is also preparing for increased competition from India\u2019s generic drugmakers, who are racing to launch cheaper versions of Wegovy once its main chemical ingredient, semaglutide, goes off patent next year.<\/p>\n

(With inputs from agencies)<\/em><\/strong><\/p>\n

\n
\n
<\/p>\n
\"Mohammad<\/figure>\n

<\/span><\/p>\n

Mohammad Haris<\/a><\/p>\n

Haris is Deputy News Editor (Business) at news18.com. He writes on various issues related to personal finance, markets, economy and companies. Having over a decade of experience in financial journalism, Haris h…Read More<\/span><\/p>\n<\/div>\n<\/div>\n

Haris is Deputy News Editor (Business) at news18.com. He writes on various issues related to personal finance, markets, economy and companies. Having over a decade of experience in financial journalism, Haris h… Read More<\/span><\/p>\n<\/div>\n<\/div>\n

Click here<\/a> to add News18 as your preferred news source on Google. Stay updated with all the latest business news, including market trends<\/a>,\u00a0stock updates<\/a>,\u00a0tax<\/a>, IPO,\u00a0banking finance<\/a>, real estate, savings and investments. To Get in-depth analysis, expert opinions, and real-time updates. Also Download the\u00a0News18 App<\/a> to stay updated.<\/span><\/div>\n
First Published:<\/span><\/p>\n
\n

October 06, 2025, 16:04 IST<\/p>\n<\/div>\n<\/div>\n

News<\/a> business<\/a> Foreign Investment Inflows: US Pharma Firm Eli Lilly to Invest $1 Billion In Telangana; Details Here<\/span><\/div>\n
\n
\n
Disclaimer: Comments reflect users\u2019 views, not News18\u2019s. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use<\/a> and Privacy Policy<\/a>.<\/div>\n<\/div>\n<\/div>\n

Read More<\/span><\/p>\n<\/div>\n


\n
Source link <\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

Last Updated:October 06, 2025, 19:31 IST Eli Lilly will invest $1 billion in Telangana to expand its manufacturing base and strengthen its global medicine supply chain. It will increase the availability of Lilly’s key drugs, including those for obesity, diabetes, Alzheimer’s, cancer and autoimmune conditions. US-based pharmaceutical giant Eli Lilly will invest $1 billion (over…<\/p>\n","protected":false},"author":1,"featured_media":17945,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[45],"tags":[],"class_list":["post-17944","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-business"],"_links":{"self":[{"href":"https:\/\/tezgyan.com\/index.php\/wp-json\/wp\/v2\/posts\/17944","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/tezgyan.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/tezgyan.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/tezgyan.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/tezgyan.com\/index.php\/wp-json\/wp\/v2\/comments?post=17944"}],"version-history":[{"count":0,"href":"https:\/\/tezgyan.com\/index.php\/wp-json\/wp\/v2\/posts\/17944\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/tezgyan.com\/index.php\/wp-json\/wp\/v2\/media\/17945"}],"wp:attachment":[{"href":"https:\/\/tezgyan.com\/index.php\/wp-json\/wp\/v2\/media?parent=17944"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/tezgyan.com\/index.php\/wp-json\/wp\/v2\/categories?post=17944"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/tezgyan.com\/index.php\/wp-json\/wp\/v2\/tags?post=17944"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}